Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
6611
|
| pubmed:dateCreated |
1988-2-24
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Dec
|
| pubmed:issn |
0267-0623
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
5
|
| pubmed:volume |
295
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1483-4
|
| pubmed:dateRevised |
2009-11-18
|
| pubmed:meshHeading |
pubmed-meshheading:3500754-Antineoplastic Agents,
pubmed-meshheading:3500754-Coformycin,
pubmed-meshheading:3500754-Drug Evaluation,
pubmed-meshheading:3500754-Humans,
pubmed-meshheading:3500754-Leukemia, Lymphoid,
pubmed-meshheading:3500754-Pentostatin,
pubmed-meshheading:3500754-Ribonucleosides,
pubmed-meshheading:3500754-Sezary Syndrome
|
| pubmed:year |
1987
|
| pubmed:articleTitle |
Response to deoxycoformycin in mature T cell malignancies.
|
| pubmed:publicationType |
Letter
|